Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death‐ligand 1 (PD‐L1) axis in post‐transplant lymphoproliferative disorders: association with Epstein–Barr virus,PD‐L1 copy number alterations,and outcome |
| |
| Authors: | Luis Veloza,Cristina Teixido,Natalia Castrejon,Fina Climent,Ana Carri ,Marta Marginet,Davide Soldini,Blanca Gonz lez‐Farr ,Inmaculada Ribera‐Cortada,Armando Lopez‐Guillermo,Eva Gonz lez‐Barca,Adriana Sierra,Mileyka Herrera,C ndida G mez,Adriana Garcia,Olga Balagu ,Elias Campo,Antonio Martinez |
| |
| Affiliation: | Luis Veloza,Cristina Teixido,Natalia Castrejon,Fina Climent,Ana Carrió,Marta Marginet,Davide Soldini,Blanca González‐Farré,Inmaculada Ribera‐Cortada,Armando Lopez‐Guillermo,Eva González‐Barca,Adriana Sierra,Mileyka Herrera,Cándida Gómez,Adriana Garcia,Olga Balagué,Elias Campo,Antonio Martinez |
| |
| Abstract: | ![]()
|
| |
| Keywords: | diffuse large B‐cell lymphoma Epstein– Barr virus FISH PD1 PD‐L1 post‐transplant lymphoproliferative disorders prognosis |
|
|
